Adjuvants are indispensable components of vaccines for stimulating optimal immune
responses to non-replicating, inactivated and subunit antigens. Eliciting balanced humoral …

In recent years, fungal vaccine research emanated significant findings in the field of
antifungal T-cell immunity. The generation of effector T cells is essential to combat many …

Candida albicans, along with several non-albicans Candida species, comprise a prominent
fungal pathogen in humans, leading to candidiasis in various organs. The global impact of …

Vaccine development tools for fungal infections are undergoing transformation where newer
technologies like nanotechnology and bioinformatics are used to create new and improved …

Vaccine adjuvant research is being fueled and driven by progress in the field of innate
immunity that has significantly advanced in the past two decades with the discovery of …

Malaria-causing Plasmodium parasites have a complex life cycle and present numerous
antigen targets that may contribute to protective immune responses. The currently …

Fungal infections are incurring high risks in a range from superficial mucosal discomforts
(such as oropharyngeal candidiasis and vulvovaginal candidiasis) to disseminated life …

Human fungal pathogens cause a broad plethora of infections, spanning cutaneous
dermatophytoses to invasive infections in immunocompromised hosts. As eukaryotic …